Clonal hematopoiesis of indeterminate potential and the risk of autoimmune diseases
Journal of Internal Medicine · 2025-06 · 297 (6) · 642-656
DOI: 10.1111/joim.20080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Internal Medicine, online erschienen am 10.03.2025. Verfasst von Hanzhang Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Big Data in Health Science, Zhejiang University School of Public Health and Department of Psychiatry, Sir Run Run Shaw Hospital, Zhejia…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Clonal Hematopoiesis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Clonal hematopoiesis of indeterminate potential (CHIP), characterized by the age‐related expansion of blood cells carrying preleukemic mutations, is associated with immune aging. This study aimed to investigate the association between CHIP and established autoimmune diseases.
Methods
We analyzed baseline data from 456,692 UK Biobank participants with available whole‐exome sequences. The primary outcome was 19 autoimmune disorders. Associations among any CHIP (variant allele fraction ≥2%), large CHIP clones (variant allele fraction ≥10%), and gene‐specific CHIP subtypes with the incidence of autoimmune diseases were assessed using Cox regression. Mediation analysis was performed to explore the role of inflammation in the link between CHIP and autoimmune diseases.
Results
We identified 17,433 any CHIP and 11,970 large CHIP at baseline. Participants with any and large CHIP were associated with 44% and 43% higher risk for Crohn's disease, 25% and 33% higher risk for psoriasis, 13% and 14% higher risk for rheumatoid arthritis, and 35% and 55% higher risk for vasculitis, respectively. Participants with CHIP status were associated with increased levels of inflammatory markers, including white blood cell, platelets, neutrophils, and neutrophil‐to‐lymphocyte ratio, with overall mediation ratios of 16.3% for Crohn's disease, 7.1% for psoriasis, 23.2% for rheumatoid arthritis, and 7.2% for vasculitis.
Conclusions
CHIP was associated with an increased risk for incident multiple autoimmune diseases, including Crohn's disease, psoriasis, vasculitis, and rheumatoid arthritis, potentially mediated by elevated inflammatory levels. Future research is needed to clarify the mechanisms underlying these associations and to explore potential interventions to reduce the associated risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Big Data in Health Science, Zhejiang University School of Public Health and Department of Psychiatry, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province, Hangzhou, China.
- Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Ningjian Wang, Xiao Tan
Zitieren
APA
Wu, H., Wei, J., Yu, Y., Wang, N., & Tan, X. (2025). Clonal hematopoiesis of indeterminate potential and the risk of autoimmune diseases. Journal of Internal Medicine, 297(6), 642-656. https://doi.org/10.1111/joim.20080
Vancouver
Wu H, Wei J, Yu Y, Wang N, Tan X. Clonal hematopoiesis of indeterminate potential and the risk of autoimmune diseases. Journal of Internal Medicine. 2025;297(6):642-656. doi:10.1111/joim.20080
BibTeX
@article{Wu2025,
author = {Wu, Hanzhang and Wei, Jiahe and Yu, Yuefeng and Wang, Ningjian and Tan, Xiao},
title = {Clonal hematopoiesis of indeterminate potential and the risk of autoimmune diseases},
journal = {Journal of Internal Medicine},
year = {2025},
volume = {297},
number = {6},
pages = {642--656},
doi = {10.1111/joim.20080}
}
EUVIMED